Skip Ribbon Commands
Skip to main content

Grants FY11-12

NMRC

  • “Sclera Cross-linking in the Experimental Rabbit Eye Model (NMRC/NIG/1049/2011)”. Dr Daphne Han; $ 199,097.00

  • “Novel Ocular Biometric Risk Factors in Primary Angle Closure (NMRC/NIG/1052/2011)”. Dr Chelvin Sng; $ 199,600.00

  • “Diabetic Retinopathy: Arresting Diabetic Retinopathy and Improving Quality of Life - Identifying the factors influencing effective diabetic management and proposing a novel care model (NMRC/NIG/1047/2011)”. Dr Gavin Siew Wei Tan; $ 199,995.40

  • “A STUDY OF THE BIODYNAMIC, BIOMECHANICAL AND MOLECULAR PROPERTIES OF THE IRIS IN ANGLE CLOSURE DISEASE (NIG11nov026)”. Dr Narayanaswamy Arun Kumar; $199,914.00

  • “Iris and Choroidal Characteristics in Asian Eyes: Elucidating the Mechanism of Primary Angle Closure Glaucoma (NIG11may029)”. Dr Cheng Ching-Yu; $192,936.00

  • “Novel Retinal Imaging as a “Biomarker” to Identify Acute Coronary Syndrome in Low-risk Chest Pain Patients Presenting to the Emergency Department (NIG11may027)”. Dr Carol Cheung; $199,940.00


BMRC

  • “Angle Closure Glaucoma: Novel methods for Imaging, Risk Assessment and Screening (10/1/35/19/674)”. Prof Aung Tin; $ 1,679,183.00

  • “Does Genetic Variation in the CFH region of Age-Related Macular Degeneration patients allow Bacteria to trigger the Disease? (10/1/35/19/671)”. Prof Wong Tien Yin; $ 1,583,259.00

  • “Development of a diagnostic and prognostic model for primary open angle glaucoma (POAG) using genomic and endophenotypic constructs (10/1/35/19/675)”. Prof Eranga N Vithana; $ 1,576,747.00

  • “Innovations in tissue engineering of selective corneal cell layers for corneal transplantation (10/1/35/19/673)”. Prof Jodhbir S Mehta; $ 2,335,500.00

  • “Intelligent Meibography imaging for the assessment of Ocular Surface Inflammation (10/1/35/19/670)”. Prof Louis Tong; $ 317,300.00

  • “Diabetic Retinopathy: novel methods in detection, pathogenesis and treatment (10/1/35/19/672)”. Prof Wong Tien Yin; $ 1,186,853.00


A*Star/Duke-NUS/MOH/Others

  • “Exploit Technologies Flagship Grant, The Development of the Branched Antimicrobial Peptides (BMAPs) Platform Technology as a Future Medicine, and Antimicrobial Agents (ETPL/10-S10FSH-0008)”. Prof Roger Beuerman; $2,429,900.00

  • “Genetic Markers of Asian Age-related Macular Degeneration (M2011068)”. Dr Belinda Kate Cornes; USD 94,561
    Singhealth:

  • “Evaluation of a novel sensor for continuous intraocular pressure monitoring in glaucoma subjects (SHF/FG428P/2010)”. Dr Mani Baskaran; $146,278.63

  • “Evaluation of OsteoMesh Implant for Eyelid Reconstruction: Pilot Study (SHF/FG486S/2010)
    In Vivo Evaluation of VEGF and Antimicrobial Peptide Bound Titanium Substrates for a Keratoprosthesis Device (SHF/FG488S/2010)”. Dr Livia Teo; $  22,065.35

  • “In Vivo Evaluation of VEGF and Antimicrobial Peptide Bound Titanium Substrates for a Keratoprosthesis Device (SHF/FG488S/2010)”. Dr Tan Xiao Wei; $  49,550.00

  • “Cytoskeleton regulators in the control of corneal fibrosis (SHF/FG489S/2010)”. “Four-year follow up of a Singapore population screened for primary angle closure ( SHF/FG485S/2010)”. Dr Zhu Hong-Yuan; $  49,997.00

  • “Four-year follow up of a Singapore population screened for primary angle closure ( SHF/FG485S/2010)”. Dr Arun Kumar Narayanaswamy; $  49,000.00

  • “The Moorfields Motion Displacement Test: A new form of perimetry for detecting glaucomatous visual field changes, a pilot study in Singapore  (SHF/FG429P/2010)”. Dr Su-Wei Alicia Claire How; $199,952.00

  • “The Immuno-genetics of Posner Schlossman syndrome with Ocular Cytomegalovirus (SHF/FG487S/2010)”. Dr Jay Siak Jyh Kuen; $  50,000.00

  • “To examine the relationship between intraocular pressure, serum osmolality and choroidal thickness during the Water Drinking Test in patients with angle closure disease (SHF/FG484S/2010)”. Dr Monisha Esther Nongpiur; $  49,300.00


Commercial

  • “A Prospective Multicenter clinical trial to evaluate the safety and effectiveness of the Acufocus TM Corneal Inlay ACI 7000PDT Implanted Intra-Stromally for Modified Monovision in Prebyopic subjects (ACU-P10-020B)”. Prof Jodhbir S Mehta; $ 278,170.82

  • “A Phase 1b/2a, Dose-escalation Study to Assess the Safety and Feasibility of a Single Intravitreal Injection of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects with Neovascular Age Related Macular Degeneration Undergoing Avastin/ Lucentis Therapy”. Prof Ian Yeo; $ 325,045.18